Impact of Fundamental Diseases on Patients With COVID-19

Disaster Med Public Health Prep. 2020 Dec;14(6):776-781. doi: 10.1017/dmp.2020.139. Epub 2020 May 7.

Abstract

Objectives: In December 2019, a new type of coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared in Wuhan, China. Serious outbreaks of coronavirus disease 2019 (COVID-19), related to the SARS-CoV-2 virus, have occurred throughout China and the world. Therefore, we intend to shed light on its potential clinical and epidemiological characteristics.

Methods: In this retrospective study, we included 50 confirmed fatal cases of SARS-CoV-2 reported on Chinese official media networks from January 16, 2020, to February 5, 2020. All the cases were confirmed by local qualified medical and health institutions. Specific information has been released through official channels. According to the contents of the reports, we recorded in detail the gender, age, first symptom date, death date, primary symptoms, chronic fundamental diseases, and other data of the patients, and carried out analyses and discussion.

Results: In total, 50 fatal cases were reported: median age was 70 y old, and males were 2.33 times more likely to die than females. The median number of days from the first symptom to death was 13, and that length of time tended to be shorter among people aged 65 and older compared with those younger than 65 (12 days vs 17 days; P = 0.046). Therefore, the older patients had fewer number of days from the first symptom to death (r = -0.40; P = 0.012).

Conclusions: In our study, we found that most of the deaths were elderly men with chronic fundamental diseases, and their COVID-19 progression to death time was shorter. At the same time, we demonstrated that older men are more likely to become infected with COVID-19, and the risk of death is positively correlated with age.

Keywords: COVID-19; SARS-CoV-2; The elderly.

MeSH terms

  • Age Distribution
  • Aged
  • COVID-19 / mortality*
  • COVID-19 / physiopathology*
  • China / epidemiology
  • Comorbidity
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • SARS-CoV-2
  • Xenopus Proteins
  • Zinc Finger Protein Gli3

Substances

  • GLI3 protein, Xenopus
  • Xenopus Proteins
  • Zinc Finger Protein Gli3